Browse > Article
http://dx.doi.org/10.4062/biomolther.2010.18.2.152

Aequorin Based Functional Assessment of the Melanin Concentrating Hormone Receptor by Intracellular Calcium Mobilization  

Lee, Sung-Hou (Department of Biomedical Technology, Sangmyung University)
Publication Information
Biomolecules & Therapeutics / v.18, no.2, 2010 , pp. 152-158 More about this Journal
Abstract
Melanin concentrating hormone is a neuropeptide highly expressed in the brain that regulates several physiological functions mediated by receptors in the G-protein coupled receptor family, especially plays an important role in the complex regulation of energy balance and body weight mediated by the melanin concentrating hormone receptor subtype 1 (MCH1). Compelling pharmacological evidence implicating MCH1 signaling in the regulation of food intake and energy expenditure has generated a great deal of interest by pharmaceutical companies as MCH1 antagonists may have potential therapeutic benefit in the treatment of obesity and metabolic syndrome. Although fluorescence-based calcium mobilization assay platform has been one of the most widely accepted tools for receptor research and drug discovery, fluorescence interference and shallow assay window limit their application in high throughput screening and have led to a growing interest in alternative, luminescence-based technologies. Herein, a luminescence-based functional assay system for the MCH1 receptor was developed and validated with the mitochondrial targeted aequorin. Aequorin based functional assay system for MCH1 presented excellent Z' factor (0.8983) and high signal-to-noise ratio (141.9). The nonpeptide MCH1 receptor antagonist, SNAP 7941 and GSK 803430, exhibited $IC_{50}$ values of 0.62 ${\pm}$ 0.11 and 12.29 ${\pm}$ 2.31 nM with excellent correlation coefficient. These results suggest that the aequorin based assay system for MCH1 is a strong alternative to the traditional GPCR related tools such as radioligand binding experiments and fluorescence functional determinations for the compound screening and receptor research.
Keywords
Melanin concentrating hormone; MCH1; Aequorin; High throughput screening; Calcium mobilization;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Bachner, D., Kreienkamp, H., Weise, C., Buck, F. and Richter, D. (1999). Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett. 457, 522-524.   DOI
2 Bittencourt, J. C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J. L., Vale, W. and Sawchenko, P. E. (1992). The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol. 319, 218-245.   DOI
3 Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Lagu, B., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Blackburn, T. P., Branchek, T. A., Gerald, C., Vaysse, P. J. and Forray, C. (2002). Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. 8, 825-830.   DOI
4 Bovolenta, S., Foti, M., Lohmer, S. and Corazza, S. (2007). Development of a Ca(2+)-activated photoprotein, Photina, and its application to high-throughput screening. J. Biomol. Screen 12, 694-704.   DOI
5 Brough, S. J. and Shah, P. (2009). Use of aequorin for G protein-coupled receptor hit identification and compound profiling. Methods Mol. Biol. 552, 181-198.   DOI
6 Burbaum, J. J. and Sigal, N. H. (1997). New technologies for high-throughput screening. Curr. Opin. Chem. Biol. 1, 72-78.   DOI
7 David, D. J., Klemenhagen, K. C., Holick, K. A., Saxe, M. D., Mendez, I., Santarelli, L., Craig, D. A., Zhong, H., Swanson, C. J., Hegde, L. G., Ping, X. I., Dong, D., Marzabadi, M. R., Gerald, C. P. and Hen, R. (2007). Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl} (4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J. Pharmacol. Exp. Ther. 321, 237-248.
8 Dupriez, V. J., Maes, K., Le Poul, E., Burgeon, E. and Detheux, M. (2002). Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors. Recept. Channels 8, 319-330.   DOI
9 Georgescu, D., Sears, R. M., Hommel, J. D., Barrot, M., Bolanos, C. A., Marsh, D. J., Bednarek, M. A., Bibb, J. A., Maratos-Flier, E., Nestler, E. J. and DiLeone, R. J. (2005). The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci. 25, 2933-2940.   DOI
10 Gilchrist, M. A. 2nd, Cacace, A. and Harden, D. G. (2008). Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening. J. Biomol. Screen 13, 486-493.   DOI
11 Hedley, L., Phagoo, S. B. and James, I. F. (1996). Measurement of intracellular calcium in cell populations loaded with aequorin: neurokinin-1 responses in U373MG cells. Anal. Biochem. 236, 270-274.   DOI
12 Pinilla, C., Appel, J. R., Borras, E. and Houghten, R. A. (2003). Advances in the use of synthetic combinatorial chemistry: mixture-based libraries. Nat. Med. 9, 118-122.   DOI
13 Le Poul, E., Hisada, S., Mizuguchi, Y., Dupriez, V. J., Burgeon, E. and Detheux, M. (2002). Adaptation of aequorin functional assay to high throughput screening. J. Biomol. Screen 7, 57-65.   DOI
14 Lembo, P. M., Grazzini, E., Cao, J., Hubatsch, D. A., Pelletier, M., Hoffert, C., St-Onge, S., Pou, C., Labrecque, J., Groblewski, T., O'Donnell, D., Payza, K., Ahmad, S. and Walker, P. (1999). The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat. Cell Biol. 1, 267-271.   DOI
15 Mashiko, S., Ishihara, A., Gomori, A., Moriya, R., Ito, M., Iwaasa, H., Matsuda, M., Feng, Y., Shen, Z., Marsh, D. J., Bednarek, M. A., MacNeil, D. J. and Kanatani, A. (2005). Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice. Endocrinology 146, 3080-3086.   DOI
16 Rink, T. J. (1990). Receptor-mediated calcium entry. FEBS Lett. 268, 381-385.   DOI
17 Chaki, S., Yamaguchi, J., Yamada, H., Thomsen, W., Tran, T. A., Semple, G. and Sekiguchi, Y. (2005). ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety. CNS Drug Rev. 11, 341-352.
18 Chambers, J., Ames, R. S., Bergsma, D., Muir, A., Fitzgerald, L. R., Hervieu, G., Dytko, G. M., Foley, J. J., Martin, J., Liu, W. S., Park, J., Ellis, C., Ganguly, S., Konchar, S., Cluderay, J., Leslie, R., Wilson, S. and Sarau, H. M. (1999). Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400, 261-265.   DOI   ScienceOn
19 Stables, J., Green, A., Marshall, F., Fraser, N., Knight, E., Sautel, M., Milligan, G., Lee, M. and Rees, S. (1997). A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal. Biochem. 252, 115-126.   DOI
20 Smith, D. G., Davis, R. J., Rorick-Kehn, L., Morin, M., Witkin, J. M., McKinzie, D. L., Nomikos, G. G. and Gehlert, D. R. (2006). Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology 31, 1135-1145.   DOI
21 Tan, C. P., Sano, H., Iwaasa, H., Pan, J., Sailer, A. W., Hreniuk, D. L., Feighner, S. D., Palyha, O. C., Pong, S. S., Figueroa, D. J., Austin, C. P., Jiang, M. M., Yu, H., Ito, J., Ito, M., Ito, M., Guan, X. M., MacNeil, D. J., Kanatani, A., Van der Ploeg, L. H. and Howard, A. D. (2002). Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics 79, 785-792.   DOI
22 Vaughan, J. M., Fischer, W. H., Hoeger, C., Rivier, J. and Vale, W. (1989). Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125, 1660-1665.   DOI
23 Hill, J., Duckworth, M., Murdock, P., Rennie, G., Sabido-David, C., Ames, R. S., Szekeres, P., Wilson, S., Bergsma, D. J., Gloger, I. S., Levy, D. S., Chambers, J. K. and Muir, A. I. (2001). Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J. Biol. Chem. 276, 20125-20129.   DOI
24 Kowalski, T. J. and McBriar, M. D. (2004). Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity. Expert Opin. Investig. Drugs 13, 1113-1122.   DOI
25 Kowalski, T. J., Spar, B. D., Weig, B., Farley, C., Cook, J., Ghibaudi, L., Fried, S., O'Neill, K., Del Vecchio, R. A., McBriar, M., Guzik, H., Clader, J., Hawes, B. E. and Hwa, J. (2006). Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Eur. J. Pharmacol. 535, 182-191.   DOI
26 Shimazaki, T., Yoshimizu, T. and Chaki, S. (2006). Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders. CNS Drugs 20, 801-811.   DOI
27 Saito, Y., Nothacker, H. P., Wang, Z., Lin, S. H., Leslie, F. and Civelli, O. (1999). Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400, 265-269.   DOI   ScienceOn
28 Saito, Y., Wang, Z., Hagino-Yamagishi, K., Civelli, O., Kawashima, S. and Maruyama, K. (2001). Endogenous melanin-concentrating hormone receptor SLC-1 in human melanoma SK-MEL-37 cells. Biochem. Biophys. Res. Commun. 289, 44-50.   DOI
29 Shearman, L. P., Camacho, R. E., Sloan Stribling, D., Zhou, D., Bednarek, M. A., Hreniuk, D. L., Feighner, S. D., Tan, C. P., Howard, A. D., Van der Ploeg, L. H., MacIntyre, D. E., Hickey, G. J. and Strack, A. M. (2003). Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eur. J. Pharmacol. 475, 37-47.   DOI
30 Walstab, J., Combrink, S., Bruss, M., Gothert, M., Niesler, B. and Bonisch, H. (2007). Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization. Anal. Biochem. 368, 185-192.   DOI
31 Wang, S., Behan, J., O'Neill, K., Weig, B., Fried, S., Laz, T., Bayne, M., Gustafson, E. and Hawes, B. E. (2001). Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, mch-r2. J. Biol. Chem. 276, 34664-34670.   DOI
32 Zhang, J. H., Chung, T. D. and Oldenburg, K. R. (1999). A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen 4, 67-73.   DOI